Home / Stocks / SAUHF

Straumann Holding AG (SAUHF, Medical devices) Stock Valuation & Fair Value

Poor on forward returns

Straumann Holding AG (SAUHF, Medical devices) trades at a current P/E of 32.5, about 7% below its historical normal valuation, with a forward growth estimate of 15.4% and a PEG of 2.11. Analysts' one-year estimates have been hit 55% of the time. Priced at its historical normal P/E of 35.1 on the same blended earnings, the 2026-11-06 close of $127.54 corresponds to about $138 a share. This is a valuation reference, not a price target. The $127.54 close is the one the P/E is read at; the technical context below uses the 2026-11-05 close, $129.75.

How to read these numbers: the PEG ratio and current P/E versus normal P/E.

DATA AS OF 2026-11-07
Current P/E
32.5
Normal P/E
35.1
PEG
2.11
Fwd growth
15.4%
Div yield
1.0%
RSI (14)
64.9
Neutral
Technical context
  • Price $129.75 at the Nov 5 close, 11.7% above the 20-day average ($116.20) and 12.9% above the 50-day ($114.94).
  • RSI (14) at 64.9.
  • 52-week range $92.11 to $135.00: the price is 3.9% below the high and 40.9% above the low.

Valuation flags

Verdict history

tickerseer's rating moved from poor on forward returns (2026-09-19) to weak on forward returns (2026-11-02). New rating rules took effect in the week of 2026-11-02, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

Current P/E and rating by weekCurrent P/E moved from 29.5 to 30.2 between 2026-09-18 and 2026-10-30, against a normal P/E of 35.1, with 3 rating changes over 7 recorded weeks.2026-09-18: P/E 29.5, Poor on forward returns, recalculated for the week of 2026-09-192026-09-18: P/E 29.5, Poor on forward returns, recorded live 2026-09-212026-09-25: P/E 30.3, Poor on forward returns, recalculated for the week of 2026-09-262026-09-25: P/E 30.3, Poor on forward returns, recorded live 2026-09-282026-10-02: P/E 28.2, Poor on forward returns, recalculated for the week of 2026-10-032026-10-02: P/E 28.2, Poor on forward returns, recorded live 2026-10-052026-10-09: P/E 26.5, Weak on forward returns, recalculated for the week of 2026-10-102026-10-09: P/E 26.5, Weak on forward returns, recorded live 2026-10-122026-10-16: P/E 28.7, Poor on forward returns, recalculated for the week of 2026-10-172026-10-16: P/E 28.7, Poor on forward returns, recorded live 2026-10-192026-10-23: P/E 30.0, Poor on forward returns, recalculated for the week of 2026-10-242026-10-23: P/E 30.0, Poor on forward returns, recorded live 2026-10-262026-10-30: P/E 30.2, Weak on forward returns, recalculated for the week of 2026-10-312026-10-30: P/E 30.2, Weak on forward returns, recorded live 2026-11-0227.530.032.535.0Sep 18Sep 28Oct 9Oct 20Oct 30Normal P/E 35.1
Weak on forward returnsPoor on forward returnsLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.

Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.

WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 29.5-16%Poor on forward returns (recalculated)
2026-09-26P/E 30.3-14%Poor on forward returns (recalculated)
2026-10-10P/E 26.5-24%Weak on forward returns (recalculated)
2026-10-17P/E 28.7-18%Poor on forward returns (recalculated)
2026-10-31P/E 30.2-14%Weak on forward returns (recalculated) (across a rating rules change)
2026-11-02P/E 30.2-14%Weak on forward returns ← now
Show all 14 readings
WeekCurrent P/EPremium to normal P/ERating
2026-09-19P/E 29.5-16%Poor on forward returns (recalculated)
2026-09-21P/E 29.5-16%Poor on forward returns
2026-09-26P/E 30.3-14%Poor on forward returns (recalculated)
2026-09-28P/E 30.3-14%Poor on forward returns
2026-10-03P/E 28.2-20%Poor on forward returns (recalculated)
2026-10-05P/E 28.2-20%Poor on forward returns
2026-10-10P/E 26.5-24%Weak on forward returns (recalculated)
2026-10-12P/E 26.5-24%Weak on forward returns
2026-10-17P/E 28.7-18%Poor on forward returns (recalculated)
2026-10-19P/E 28.7-18%Poor on forward returns
2026-10-24P/E 30.0-15%Poor on forward returns (recalculated)
2026-10-26P/E 30.0-15%Poor on forward returns
2026-10-31P/E 30.2-14%Weak on forward returns (recalculated) (across a rating rules change)
2026-11-02P/E 30.2-14%Weak on forward returns ← now

Frequently asked questions

Is Straumann Holding AG stock overvalued?

At a current P/E of 32.5 versus its historical normal P/E of 35.1, Straumann Holding AG trades about 7% below its typical valuation, with a PEG of 2.11 on 15.4% forward growth. tickerseer currently rates it poor on forward returns.

What is Straumann Holding AG's fair value and PEG?

Straumann Holding AG trades at a current P/E of 32.5 against a historical normal P/E of 35.1, a PEG of 2.11, and a forward growth estimate of 15.4%. Priced at its historical normal P/E of 35.1 on the same blended earnings, the 2026-11-06 close of $127.54 corresponds to about $138 a share. This is a valuation reference, not a price target.

Has tickerseer's rating of Straumann Holding AG changed?

tickerseer's rating moved from poor on forward returns (2026-09-19) to weak on forward returns (2026-11-02). New rating rules took effect in the week of 2026-11-02, and this rating moved across that change, so part of the move may come from the new rules rather than the company.

Industry: Medical devices. Create a free account to see the full analysis: the SeerAI score, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track SAUHF free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.